Manufacturing

Articles

Locate Bio has been granted additional investment to the tune of £2 million (US$2.6 million) for the expansion of its cell and gene therapy pipeline.

Locate Bio Receives Investment to Expand its Cell and Gene Therapy Pipeline

In collaboration with Pall Corportion, biotech company Freeline completed the first full-scale run at its newly commissioned, GMP gene-therapy manufacturing facility in the UK.

Freeline Installs Pall System at Gene Therapy Facility

NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.

NJII and Pall Partner on Cell and Gene Therapy Manufacturing Development

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium. 

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

Walter Colasante is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice. 

Pascale Diesel is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.

Think ahead to production requirements when planning strategies in early development of gene and cell therapies.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapy

The new facility, located at the company’s headquarters in Pittsburgh, PA, is expected to meet all clinical and commercial development needs of the company’s lead gene therapy program.

Krystal Biotech Opens Gene-Therapy Manufacturing Facility

The acquisition will establish a clinical pipeline for Biogen of gene-therapy candidates in ophthalmology.

Biogen to Acquire Gene-Therapy Company Nightstar in $800-Million Deal

AST will unveil its multi-format robotic filling system, the GENiSYS R, at INTERPHEX. 

Robotic Aseptic Filling and Closing Machine Designed for Cell and Gene Therapies

A multi-partner collaboration has been announced, which will target the acceleration of the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cell lines.

Multi-Partner Collaboration Set to Speed Up Development of Microfluidic Systems for Gene Editing

The company will invest an additional $60 million to expand its manufacturing facility in Durham County, NC.

Manufacturing, Gene Therapies